Harbin Medical University Third Affiliated Hospital
Harbin Medical University Third Affiliated Hospital
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, adenocarcinoma, carcinoma, diabetes mellitus, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hepatocellular carcinoma, liver disorder, metabolic disease, neoplasm | Not yet recruiting | Phase 2 | 2026-09-21 | NCT07557914 | |
| The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, hypopharyngeal carcinoma, neoplasm, otorhinolaryngologic disease | Recruiting | Not applicable | 2025-12-30 | NCT05494190 |